ARTICLE | Company News
Almac, Genentech, Roche deal
June 22, 2015 7:00 AM UTC
Almac’s Almac Discovery oncology subsidiary granted Roche’s Genentech unit exclusive, worldwide rights to develop and commercialize a preclinical ubiquitin-specific protease inhibitor. Genentech plans...